Australia Medical Oxygen Concentrator Market Insights Forecasts to 2033

• The Australia Medical Oxygen Concentrator Market Size was valued at USD 59.5 Million in 2023.
• The Market Size is Growing at a CAGR of 11.86% from 2023 to 2033
• The Australia Medical Oxygen Concentrator Market Size is Expected to Reach USD 182.5 Million by 2033

The Australia Medical Oxygen Concentrator Market Size is Anticipated to Reach USD 182.5 Million by 2033, Growing at a CAGR of 11.86% from 2023 to 2033

Market Overview

A medical oxygen concentrator is a device which provides patients who have difficulties inhaling or whose blood oxygen levels are low with pure oxygen. Oxygenators extract and concentrate oxygen from the ambient air and distribute it through the hood or nose. It has wide application for oxygen therapy, which is performed in health care institutions or at patients' places. Compressed oxygen gas must be stored in suitable oxygen tanks. It should be used whenever compressed oxygen is likely to be present in a location where the oxygen compressor cannot be accessed. Oxygen concentrators can be used to treat many diseases such as asthma, bronchitis, heart disease, cell damage in the lungs, chronic obstructive pulmonary disease, bronchitis, respiratory shock, and sleep apnea. According to the National Drug Strategy Household Survey (NDSHS), an estimated 1.8 million people in Australia smoke daily in 2022-23. According to the NDSHS, the highest rate of regular smoking was among people in their 40s and 60s at 8.8% and 10.4% respectively. [MH1] The report of the Australian Institute of Health and Welfare claims that in 2022, the age-standardized death rate for males in Australia was almost 11% for coronary heart disease.[MH2] 

Report Coverage

This research report categorizes the market for the Australia medical oxygen concentrator market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Australia medical oxygen concentrator market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Australia medical oxygen concentrator market.

Driving Factors

Asthma, interstitial pneumonia, and chronic obstructive pulmonary disease are chronic diseases of the respiratory system. The most general form of long-term oxygen therapy is now widely used to improve quality of life by reducing symptoms of fatigue and dyspnea hence equipment for oxygen therapy. There is a huge increase in growth, and this remains to be one of the major factors driving market expansion. This is because the country’s respiratory rate problems keep rising as attributed to causes such as air pollution, smoking, and an aging population. The population of the country is aging rapidly. Older people form an ever-growing number, especially in affluent countries. Since comorbidities are most common in older adults and age-related changes in lung function might make them more susceptible to respiratory diseases because older people suffering from respiratory problems often require oxygen therapy, the demand for chemical oxygen concentrators and oxygen cylinders will rise consistently with a growing number of older persons.

Restraining Factors

The usage of oxygen therapy is increasing in Australia, but medical use of oxygen remains to be minimal. Due to portable and minimal maintenance with no need for electricity, portable oxygen cylinders remain to be preferred in hospitals. Pure oxygen tanks are more reliable and require less maintenance compared to the remaining two types of oxygen tanks. In case the equipment fails or if there is a power shortage, an oxygen cylinder is the ideal backup.

Market Segmentation

The Australia medical oxygen concentrator market share is classified into product, technology, and end-users.

• The portable oxygen concentrator segment is expected to hold the largest market share through the forecast period.

The Australia medical oxygen concentrator market is segmented by product into portable oxygen concentrators and stationary oxygen concentrators. Among these, the portable oxygen concentrator segment is expected to hold the largest market share through the forecast period. The portable oxygen concentrator is expected to dominate the market during the forecasted period by holding the highest share. The benefits of portable oxygen concentrators, such as portability and easier use by the geriatric population, are some factors that may be addressed as drivers for this segment.

• The continuous dose segment is expected to dominate the Australia medical oxygen concentrator market during the forecast period.       

Based on the technology, the Australia medical oxygen concentrator market is divided into policy continuous dose and pulse dose. Among these, the continuous dose segment is expected to dominate the Australia medical oxygen concentrator market during the forecast period. The Federal Aviation Administration (FAA), has authorized continuous oxygen concentrators. This means that users can fly the device in this country or abroad. Additionally, these devices do not have the technology to find breathability, making them less expensive than high-pressure technologies.

• The home care segment is expected to hold the largest market share through the forecast period.

The Australia medical oxygen concentrator market is segmented by end-users into hospitals, clinics, home care, and travelers. Among these, the home care segment is expected to hold the largest market share through the forecast period. The market will grow because of pure oxygen, home health oxygen therapy, and technological developments such as the smaller size of these devices that reduce their size. Australia is at risk of more respiratory and lung problems due to rapid growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Australia medical oxygen concentrator market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Invacare Corporation
• Philips Respironics
• Caire Inc.
• Invacare Corporation
• Inogen, Inc.
• Drive Devilbiss Healthcare
• Nidek Medical Products Inc.
• Sysmed (China) Co., Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Australia, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Australia medical oxygen concentrator market based on the below-mentioned segments:

Australia Medical Oxygen Concentrator Market, By Product

• Portable Oxygen Concentrator
• Stationary Oxygen Concentrator

Australia Medical Oxygen Concentrator Market, By Technology

• Continuous Dose
• Pulse Dose

Australia Medical Oxygen Concentrator Market, By End-User

• Home care
• Travel
• Hospital
• Clinic